Human Antibody Discovery

Over 60 global pharmaceutical companies, large and small, rely on Abveris to develop therapeutic antibody candidates.

Our Boston-based team of discovery scientists is composed of experienced biotherapeutic drug discovery scientists with a passion for novel antibody discovery.  We use advanced immunization techniques, engineered in vivo systems, optimized antibody capture methods, robust high-throughput screening technologies, and diverse ancillary capabilities to deliver excellent therapeutic leads with critical timelines in mind.

• Our team is experienced in biologic drug discovery with a variety of humanized mice. This experience is important when our clients are relying on us to deliver the next generation of biologics against increasingly difficult targets
• A big toolbox enables us to tackle a diverse set of challenges
  • Antigen and screening materials development
  • Multiple immunization techniques including: DNA immunization, cell immunization, rapid protocols, adjuvants to break tolerance and assist in cross-reactivity and more
  • Highly efficient B cell screening and hybridoma approaches
  • High-throughput, industry-leading screening tools to identify ideal mAbs including the iQue flow cytometer along with the Octet and Carterra systems for affinity, activity and epitope binning analysis.
  • In-house sequencing capabilities
• All work performed in our Boston Area location
• Expert project management with a thoughtful and collaborative communication style